Gyre Therapeutics, Inc. (GYRE) Shareholders’ equity 2013–2025
Gyre Therapeutics, Inc. (GYRE) shareholders’ equity at each fiscal year-end, per SEC filings.
$106.0MFY2025 · since FY2013: -$103.0M → $106.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $106.0M | +67.5% |
| FY2024 | $63.3M | +500.0% |
| FY2023 | -$15.8M | -137.2% |
| FY2022 | $42.5M | +3.5% |
| FY2021 | $41.1M | -46.0% |
| FY2020 | $76.1M | — |
| FY2018 | $119.9M | +289.8% |
| FY2017 | $30.8M | — |
| FY2014 | -$109.4M | -6.2% |
| FY2013 | -$103.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice